SCHEMBL29939457

SCHEMBL29939457

CCOC(=O)CC(=O)c1ccc(C)nc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
KMT2A Q03164 4/20 0.48
KDM4E B2RXH2 2/20 0.48
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 2/20 0.48
TSHR P16473 1/20 0.44
MGAM O43451 1/20 0.44
GAA P10253 1/20 0.44
SI P14410 1/20 0.44
MGAM2 Q2M2H8 1/20 0.44
MAPT P10636 4/20 0.43
CXCR1 P25024 1/20 0.42
CXCR2 P25025 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
DGAT1 O75907 1/20 0.41
HPGD P15428 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10662120 1.00 HDAC1 (0.51) HDAC1HDAC6KMT2AKDM4EMEN1
SCHEMBL4734775 0.87 HDAC1 (0.54) HDAC1HDAC6KMT2AKDM4EMEN1
SCHEMBL23149668 0.86 ALDH1A1 (0.47) KMT2AKDM4EMEN1ALDH1A1TSHR
SCHEMBL3539766 0.86 POLB (0.53) HDAC1HDAC6KMT2AKDM4EMEN1
SCHEMBL10658130 0.86 HDAC1 (0.46) HDAC1HDAC6KMT2AKDM4EMEN1
SCHEMBL30786505 0.86 ALDH1A1 (0.47) KMT2AKDM4EMEN1ALDH1A1TSHR
SCHEMBL29939525 0.84 ALDH1A1 (0.46) KMT2AKDM4EMEN1ALDH1A1TSHR
SCHEMBL3173315 0.84 DGAT1 (0.60) KMT2AKDM4EMEN1ALDH1A1GAA
SCHEMBL3656932 0.84 KMT2A (0.46) HDAC1HDAC6KMT2AKDM4EMEN1
SCHEMBL5752823 0.84 CXCR1 (0.46) KMT2AKDM4EMEN1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12227507-B2 Pharmaceutical compounds PFIZER INC. (US) 2025-02-18 US disclosed
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 US disclosed
CN-115348962-A As GABA A Naphthyridines and pyrido [3,4-c ] of alpha 5 receptor modulators]Pyridazine derivatives 吉瑞工厂 2022-11-15 CN disclosed
US-20220324873-A1 PHARMACEUTICAL COMPOUNDS PFIZER INC. 2022-10-13 US disclosed
US-20220306639-A1 PHARMACEUTICAL COMPOUNDS PFIZER INC. 2022-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227507-B2 Pharmaceutical compounds CHRNA6, GABRA6, CHRNA7 HDAC1 897/4885HDAC6 643/4885KMT2A 3557/4885
US-11634425-B2 Pharmaceutical compounds GABRA6, CHRNA6, CNR1 HDAC1 921/4885HDAC6 665/4885KMT2A 3408/4885
US-20220306639-A1 PHARMACEUTICAL COMPOUNDS CHRNA6, GABRA6, CHRNA7 HDAC1 897/4885HDAC6 643/4885KMT2A 3557/4885
US-20220324873-A1 PHARMACEUTICAL COMPOUNDS GABRA6, CNR1, CHRNA6 HDAC1 740/4885HDAC6 593/4885KMT2A 3193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.